| Structure |
Chemical Name |
CAS |
MF |
 |
Ibrutinib Impurity 37 |
330793-49-2 |
C10H13IN6 |
![(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol](/CAS/20200401/GIF/CB65519826.gif) |
(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol |
|
C11H19N3OS |
 |
(trans)-4-((6-amino-2,3-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
ERYTHROMYCIN IMPURITY N |
|
|
 |
Fesoterodine Impurity 12 |
|
|
 |
Dexamethasone EP impurities D |
|
|
 |
Palbociclib impurity LMAP |
|
|
 |
(3R,3'R)-3,3'-((((S)-1-amino-1-oxobutan-2-yl)azanediyl)bis(methylene))dihexanoic acid |
|
C18H34N2O5 |
 |
Acetaminophen EP Impurity L |
|
C8H9NO2 |
 |
(R)-4-(2-(benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol |
317351-40-9 |
C16H19NO3 |
 |
N,N'-Bis(4-hydroxyphenyl)hydrazine |
158905-63-6 |
C12H12N2O2 |
 |
Droxidopa Impurity M |
|
|
 |
Aripiprazole peroxide degradation Impurity (MW:464Da) |
|
|
 |
Zileuton Impurity (MW = 279.31 Da) |
|
|
 |
Rivaroxaban Impurity 81 |
|
|
 |
Gadobutrol Impurity 21 |
|
|
 |
Flucloxacillin sodium EP Impurity E |
|
|
 |
Pyrazole |
|
|
 |
Cephalomannine (Paclitaxel Impurity I) |
|
|
 |
METOPROLOL IMPURITY D |
|
C15H25NO3 |
 |
NITRENDIPINE IMPURITY A |
|
|
 |
TAMSULOSIN IMPURITY D |
|
C20H28N2O5S |
 |
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
 |
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
 |
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
C11H14N4O4 |
 |
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
 |
Rifampin Impurity 6 |
|
|
 |
Cefuroxime Dioxide Impurity(Cefuroxime Sulfoxide) |
|
|
 |
Ampicillin Impurity F(USP) |
|
|
 |
Miconazole Impurity G(EP) |
1370335-40-2 |
C18H14Cl4N2O |
![2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one](/) |
2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
![2-(5H-chromeno[2,3-b]pyridin-7-yl)acrylic acid](/CAS/20210305/GIF/52549-22-1.gif) |
2-(5H-chromeno[2,3-b]pyridin-7-yl)acrylic acid |
52549-22-1 |
C15H11NO3 |
 |
1-(6-chloro-5-fluoropyrimidin-4-yl)ethanol |
1289559-76-7 |
C6H6ClFN2O |
![Fluoxetine Impurity 29,methyl({3-phenyl-3-[2-(trifluoromethyl)phenoxy]propyl})amine](/CAS/20210305/GIF/56161-71-8.gif) |
Fluoxetine Impurity 29,methyl({3-phenyl-3-[2-(trifluoromethyl)phenoxy]propyl})amine |
56161-71-8 |
C17H18F3NO |
 |
(Z)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
 |
Ceftriaxone sodium impurity 09 |
|
|
 |
Cefradine Impurity 8 |
30959-67-2 |
C16H19N3O4S |
 |
Biotin Impurity |
171232-73-8 |
C19H18N2O2S |
 |
PANTOPRAZOLE N-OXIDE |
953787-60-5 |
C16H15F2N3O5S |
 |
N-(3-GUANIDINO-4-METHYLPHENYL)-4-(METHYLPIPERAZINE-1-YL-METHYL)BENZAMIDE |
581076-65-5 |
C21H28N6O |
 |
Tirofiban-d9 Hydrochloride |
1331911-68-2 |
C22H37ClN2O5S |
 |
イブプロフェンアルコール |
36039-36-8 |
C13H20O |
![1,1-ビス[4-(2-メチルプロピル)フェニル]エタン](/CAS/GIF/102120-87-6.gif) |
1,1-ビス[4-(2-メチルプロピル)フェニル]エタン |
102120-87-6 |
C22H30 |
 |
Sugammadex sodium Impurity 52 |
|
|
 |
Sugammadex sodium Impurity 43 |
|
|
 |
Sugammadex sodium Impurity 39 |
|
|
 |
Cefazolin Impurity EP-J |
|
|
 |
Cabozantinib impurity 41 |
|
|
 |
Cabozantinib impurity 67 |
|
|
 |
Dapoxetine impurity 50 |
|
|
 |
Doxofylline Impurity 18 |
|
|
 |
Dapoxetine impurity 63 |
|
|
 |
Dapoxetine impurity 57 |
|
|
 |
Bosutinib Impurity 2 (N-Desmethyl Bosutinib) |
380843-81-2 |
C25H27Cl2N5O3 |
 |
4-PYRIDINECARBOXIMIDIC ACID, HYDRAZIDE |
89830-71-7 |
C6H8N4 |
 |
2-(1-オキソペンチル)安息香酸 |
550-37-8 |
C12H14O3 |
 |
炭酸クロロメチルエチル |
35179-98-7 |
C4H7ClO3 |
 |
Bimatoprost Impurity 10 |
|
|
 |
Carbetocin S-Oxide II |
|
|
 |
Empagliflozin Impurity 82 |
2452301-16-3 |
C17H16ClIO2 |
 |
Empagliflozin Impurity 88 |
|
|
 |
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
 |
Olopatadine Impurity 13 |
55453-90-2 |
C18H16O4 |
 |
4-((2-amino-2-oxoethyl)amino)butanoic acid |
1096803-44-9 |
C6H12N2O3 |
 |
Lenvatinib impurity LFZZ-17 |
|
C11H9NO4 |
 |
Ornidazole Impurity 25 |
|
|
 |
Pitavastatin Impurity 72 |
|
|
 |
Febuxostat Impurity 109 |
|
|
 |
Brivaracetam Impurity 37 |
|
|
 |
Ticagrelor Impurity 133 |
|
|
![4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide](/CAS/20200611/GIF/1187188-59-5.gif) |
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
![2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]-](/CAS/20200611/GIF/219915-41-0.gif) |
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
![L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]-](/CAS/20200611/GIF/61475-35-2.gif) |
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
 |
アゾベンゼン-2-オール |
2362-57-4 |
C12H10N2O |
 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
 |
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/936226-36-7.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)-](/CAS/20210111/GIF/946525-39-9.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
 |
Topiroxostat Impurity 42 |
|
|
 |
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
 |
Regorafenib Impurity MHY |
|
|
 |
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
 |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
 |
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-](/CAS/20200611/GIF/2247538-61-8.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
 |
Vonoprazan Impurity B-3 |
|
|
![3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-51-2.gif) |
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
 |
Budesonide Impurity 26 |
|
|
 |
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
 |
Piperacillin ImpurityABCDEFGHI |
|
|
 |
5,6-ジメトキシ-2-(4-ピリジルメチル)-1-インダノン |
4803-57-0 |
C17H17NO3 |
 |
3-(ジメチルアミノ)-1-(2-チエニル)-1-プロパノール |
13636-02-7 |
C9H15NOS |
 |
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
349086-08-4 |
C12H15Cl2NO |
![3-[(4-アミノ-2-メチル-5-ピリミジニル)メチル]-5-(2-クロロエチル)-4-メチルチアゾール-3-イウム·クロリド](/CAS/20180808/GIF/13471-78-8.gif) |
3-[(4-アミノ-2-メチル-5-ピリミジニル)メチル]-5-(2-クロロエチル)-4-メチルチアゾール-3-イウム·クロリド |
13471-78-8 |
C12H16Cl2N4S |
 |
2-メトキシ-5-スルホ安息香酸1-メチル |
94134-07-3 |
C9H10O6S |
![2,4-ジオキソ-3-アザスピロ[5.5]ウンデカン-1,5-ジカルボニトリル](/CAS/GIF/4355-15-1.gif) |
2,4-ジオキソ-3-アザスピロ[5.5]ウンデカン-1,5-ジカルボニトリル |
4355-15-1 |
C12H13N3O2 |
 |
Sugammadex Impurity 12 Monomer(Org198958-2(RRT0.45)) |
2412953-11-6 |
C72H112O49S8 |
![Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2300968-85-6.gif) |
Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl- |
2300968-85-6 |
C19H22N6O4S |
 |
Acetamide, 2-chloro-N-(2-chloroacetyl)-N-(2,6-dimethylphenyl)- |
112843-97-7 |
C12H13Cl2NO2 |
 |
β-シアノイミノ-1-ピペリジンプロピオノニトリル |
56488-00-7 |
C9H12N4 |